Tandem Diabetes Care | TNDM - 销售收入



金融业
股票价格
USD
资产
USD 1.15B
现金及等价物
USD 179.33M
销售成本
USD 122.92M
流动资产
USD 887.1M
流动负债
USD 247.96M
债务
USD 444.48M
EBIT
USD 8.29M
EBITDA
USD 2.73M
员工
2.65K
EPS每股收益
USD -0.3
股本和储备
USD 132.4M
销售毛利
USD 167.46M
债务利息支出
USD 1.15B
利息收入
USD 3.02M
贷款资金
USD 601.77M
市值
USD 841.4M
净收入
USD -589K
营业费用
USD 282.09M
营业利润
USD 8.29M
普通股股本
USD 68.29M
PE价格收益
681.05
税前利润
USD 4.68M
销售收入
USD 247.22M
销售和管理费用
USD 99.86M
股票
USD 126.4M
贸易债权人
USD 59.86M
应收帐款人
USD 165.49M


销售 更改 日
Abbott USD 11.16B 300M 2026-03
Accuray USD 116.17M 14.63M 2024-12
Align Technology USD 1.04B 10M 2026-03
AtriCure USD 141.2M 700K 2026-03
Baxter International USD 2.7B 270M 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
ICU Medical USD 525.77M 14.93M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Masimo USD 403.6M 8.9M 2026-03
Medtronic USD 9B 39M 2026-01
Merit Medical Systems USD 381.9M 12M 2026-03
Orthofix International USD 219.91M 14.28M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Zimmer Biomet Holdings USD 2.09B 150M 2026-03